Pharmacokinetic drug interaction of mycophenolate with co-amoxiclav in renal transplant patients.
暂无分享,去创建一个
[1] P. Marquet,et al. Individualized Mycophenolate Mofetil Dosing Based on Drug Exposure Significantly Improves Patient Outcomes After Renal Transplantation , 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[2] R. Borrows,et al. The Magnitude and Time Course of Changes in Mycophenolic Acid 12-Hour Predose Levels During Antibiotic Therapy in Mycophenolate Mofetil-Based Renal Transplantation , 2007, Therapeutic drug monitoring.
[3] B. Mathew,et al. A six-hour extrapolated sampling strategy for monitoring mycophenolic acid in renal transplant patients in the Indian subcontinent. , 2006, Journal of postgraduate medicine.
[4] R. Morris,et al. ROLE OF MRP2 IN THE HEPATIC DISPOSITION OF MYCOPHENOLIC ACID AND ITS GLUCURONIDE METABOLITES: EFFECT OF CYCLOSPORINE , 2006, Drug Metabolism and Disposition.
[5] E. Heinzen,et al. The Influence of Norfloxacin and Metronidazole on the Disposition of Mycophenolate Mofetil , 2005, Journal of clinical pharmacology.
[6] A. Nicholls,et al. Clinical Pharmacokinetics of Mycophenolate Mofetil , 1998, Clinical pharmacokinetics.